NasdaqCM - Nasdaq Real Time Price USD

Semler Scientific, Inc. (SMLR)

34.84
+0.05
+(0.14%)
At close: 4:00:01 PM EDT
35.49
+0.65
+(1.87%)
After hours: 7:28:41 PM EDT
Loading Chart for SMLR
  • Previous Close 34.79
  • Open 36.67
  • Bid 34.63 x 500
  • Ask 35.50 x 500
  • Day's Range 34.46 - 37.10
  • 52 Week Range 21.03 - 81.56
  • Volume 858,140
  • Avg. Volume 403,105
  • Market Cap (intraday) 404.008M
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) 6.79
  • EPS (TTM) 5.13
  • Earnings Date May 13, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

www.semlerscientific.com

79

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SMLR

View More

Performance Overview: SMLR

Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SMLR
35.48%
S&P 500 (^GSPC)
0.64%

1-Year Return

SMLR
52.01%
S&P 500 (^GSPC)
11.90%

3-Year Return

SMLR
21.65%
S&P 500 (^GSPC)
48.70%

5-Year Return

SMLR
16.85%
S&P 500 (^GSPC)
103.62%

Compare To: SMLR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SMLR

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    403.43M

  • Enterprise Value

    388.58M

  • Trailing P/E

    6.78

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.93

  • Price/Book (mrq)

    1.75

  • Enterprise Value/Revenue

    6.90

  • Enterprise Value/EBITDA

    18.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    72.65%

  • Return on Assets (ttm)

    8.23%

  • Return on Equity (ttm)

    27.04%

  • Revenue (ttm)

    56.29M

  • Net Income Avi to Common (ttm)

    40.9M

  • Diluted EPS (ttm)

    5.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.92M

  • Total Debt/Equity (mrq)

    0.03%

  • Levered Free Cash Flow (ttm)

    15.49M

Research Analysis: SMLR

View More

Company Insights: SMLR

Research Reports: SMLR

View More

People Also Watch